145 related articles for article (PubMed ID: 2882148)
21. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
Juby LD; Burke DA; Axon AT
Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
[TBL] [Abstract][Full Text] [Related]
22. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
[TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide secreting tumours in children: a case report with literature review.
Quak SH; Prabhakaran K; Kwok R; O'Reilly AP
Aust Paediatr J; 1988 Feb; 24(1):55-8. PubMed ID: 2833214
[TBL] [Abstract][Full Text] [Related]
24. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.
Ruskoné A; René E; Chayvialle JA; Bonin N; Pignal F; Kremer M; Bonfils S; Rambaud JC
Dig Dis Sci; 1982 May; 27(5):459-66. PubMed ID: 6122550
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal polypeptide-, somatostatin-, and calcitonin-producing adrenal pheochromocytoma associated with the watery diarrhea (WDHH) syndrome. First case report with immunohistochemical findings.
Viale G; Dell'Orto P; Moro E; Cozzaglio L; Coggi G
Cancer; 1985 Mar; 55(5):1099-106. PubMed ID: 2857107
[TBL] [Abstract][Full Text] [Related]
26. [A case report of vasoactive intestinal Peptide tumors].
Zhag SL; Zhao GF; Hao RF; Zheng HY
Ai Zheng; 2007 Sep; 26(9):1039-40. PubMed ID: 17927869
[No Abstract] [Full Text] [Related]
27. [Pancreatic vipoma with bizarre characteristics].
Bermejo F; Moreno L; Moreira V; Gisbert JP; González Palacios F; García López JL
Gastroenterol Hepatol; 1999 Mar; 22(3):132-5. PubMed ID: 10228323
[TBL] [Abstract][Full Text] [Related]
28. Metastatic vipoma arising from colonic primary tumour.
Bradley C; Haddock G; Pickard RG; Rankin EM
Eur J Surg Oncol; 1989 Aug; 15(4):386-9. PubMed ID: 2547666
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic vasoactive intestinal polypeptide-oma as a cause of secretory diarrhoea.
Masel SL; Brennan BA; Turner JH; Cullingford GL; Cullen DJ
J Gastroenterol Hepatol; 2000 Apr; 15(4):457-60. PubMed ID: 10824894
[TBL] [Abstract][Full Text] [Related]
30. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.
Bloom SR; Yiangou Y; Polak JM
Ann N Y Acad Sci; 1988; 527():518-27. PubMed ID: 2839088
[No Abstract] [Full Text] [Related]
31. Cyclical release of vasoactive intestinal polypeptide (VIP) from a pancreatic islet cell apudoma.
Devine BL; Carmichael HA; Russell RI; Joffe SN
Postgrad Med J; 1978 Aug; 54(634):566-70. PubMed ID: 215990
[TBL] [Abstract][Full Text] [Related]
32. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
Clements D; Elias E
Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
[No Abstract] [Full Text] [Related]
33. Percutaneous Irreversible Electroporation for Pancreatic VIPoma: A Case Report.
Niu L; Li J; Zeng J; Fang G; Zhou L; Xu K; Zhang K
Pancreas; 2017 Jan; 46(1):135-137. PubMed ID: 27977628
[TBL] [Abstract][Full Text] [Related]
34. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
35. Benign pancreatic vipoma.
Alvite-Canosa M; Alonso-Fernández L; Seoane-López M; Pérz-Grobas J; Berdeal-Díaz M; Carral-Freire M; Bouzón-Alejandro A; Gómez-Dovigo A; Aguirrezabalaga-González J
Rev Esp Enferm Dig; 2011 Apr; 103(4):224-5. PubMed ID: 21526882
[No Abstract] [Full Text] [Related]
36. Islet cell tumors of the pancreas: clinico-biochemical correlations.
Khandekar JD
Ann Clin Lab Sci; 1979; 9(3):212-8. PubMed ID: 223492
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal polypeptide-secreting tumours (vipomas) in childhood.
Long RG
J Pediatr Gastroenterol Nutr; 1983; 2(1):122-6. PubMed ID: 6310076
[No Abstract] [Full Text] [Related]
38. A patient with Verner-Morrison's syndrome--a vasoactive intestinal peptide (VIP)-mediated watery diarrhoea syndrome?
Meuwese-Arends MT; Yap SH; Van Tongeren JH
Neth J Med; 1980; 23(2):107-10. PubMed ID: 6246463
[No Abstract] [Full Text] [Related]
39. [Metabolic control of insulinoma with a prolonged-action somatostatin agonist].
Kaloustian E
Presse Med; 1986 Oct; 15(37):1881-2. PubMed ID: 2878428
[No Abstract] [Full Text] [Related]
40. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
